These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 25885821)
41. Implementation of human papillomavirus video education for women participating in mass cervical cancer screening in Tanzania. Cooper EC; Maher JA; Naaseh A; Crawford EW; Chinn JO; Runge AS; Lucas AN; Zezoff DC; Bera KR; Dinicu AI; White KM; Tewari SE; Hari A; Bernstein M; Chang J; Ziogas A; Pearre DC; Tewari KS Am J Obstet Gynecol; 2021 Jan; 224(1):105.e1-105.e9. PubMed ID: 32682861 [TBL] [Abstract][Full Text] [Related]
42. Performance of p16INK4a ELISA as a primary cervical cancer screening test among a large cohort of HIV-infected women in western Kenya: a 2-year cross-sectional study. Wu TJ; Smith-McCune K; Reuschenbach M; von Knebel Doeberitz M; Maloba M; Huchko MJ BMJ Open; 2016 Sep; 6(9):e012547. PubMed ID: 27625065 [TBL] [Abstract][Full Text] [Related]
43. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program. Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820 [TBL] [Abstract][Full Text] [Related]
44. The use of thermal ablation in diverse cervical cancer "screen-and-treat" service platforms in Zambia. Mwanahamuntu M; Kapambwe S; Pinder LF; Matambo J; Chirwa S; Chisele S; Basu P; Prendiville W; Sankaranarayanan R; Parham GP Int J Gynaecol Obstet; 2022 Apr; 157(1):85-89. PubMed ID: 34197624 [TBL] [Abstract][Full Text] [Related]
45. Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia. Al-Mandeel HM; Sagr E; Sait K; Latifah HM; Al-Obaid A; Al-Badawi IA; Alkushi AO; Salem H; Massoudi NS; Schunemann H; Mustafa RA; Brignardello-Petersen R Ann Saudi Med; 2016; 36(5):313-320. PubMed ID: 27710981 [TBL] [Abstract][Full Text] [Related]
46. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India. Sahasrabuddhe VV; Bhosale RA; Kavatkar AN; Nagwanshi CA; Joshi SN; Jenkins CA; Shepherd BE; Kelkar RS; Sahay S; Risbud AR; Vermund SH; Mehendale SM Int J Cancer; 2012 Jan; 130(1):234-40. PubMed ID: 21387289 [TBL] [Abstract][Full Text] [Related]
47. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. Blumenthal PD; Lauterbach M; Sellors JW; Sankaranarayanan R Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S30-7. PubMed ID: 15823264 [TBL] [Abstract][Full Text] [Related]
48. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia. Kapambwe S; Sahasrabuddhe VV; Blevins M; Mwanahamuntu MH; Mudenda V; Shepherd BE; Chibwesha CJ; Pfaendler KS; Hicks ML; Vermund SH; Stringer JS; Parham GP J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e20-6. PubMed ID: 26322673 [TBL] [Abstract][Full Text] [Related]
49. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs. Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541 [TBL] [Abstract][Full Text] [Related]
50. Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon. DeGregorio GA; Bradford LS; Manga S; Tih PM; Wamai R; Ogembo R; Sando Z; Liu Y; Schwaiger C; Rao SR; Kalmakis K; Kennedy Sheldon L; Nulah K; Welty E; Welty T; Ogembo JG PLoS One; 2016; 11(6):e0157319. PubMed ID: 27280882 [TBL] [Abstract][Full Text] [Related]
51. Screening for cervical neoplasia in an unselected rural Guatemalan population using direct visual inspection after acetic acid application: a pilot study. Mathers LJ; Wigton TR; Leonhardt JG J Low Genit Tract Dis; 2005 Oct; 9(4):232-5. PubMed ID: 16205195 [TBL] [Abstract][Full Text] [Related]
52. 'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia. White HL; Mulambia C; Sinkala M; Mwanahamuntu MH; Parham GP; Moneyham L; Grimley DM; Chamot E Soc Sci Med; 2012 May; 74(10):1486-93. PubMed ID: 22459188 [TBL] [Abstract][Full Text] [Related]
53. Successes and challenges of establishing a cervical cancer screening and treatment program in western Kenya. Khozaim K; Orang'o E; Christoffersen-Deb A; Itsura P; Oguda J; Muliro H; Ndiema J; Mwangi G; Strother M; Cu-Uvin S; Rosen B; Washington S Int J Gynaecol Obstet; 2014 Jan; 124(1):12-8. PubMed ID: 24140218 [TBL] [Abstract][Full Text] [Related]
54. Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya. Shin MB; Oluoch LM; Barnabas RV; Baynes C; Fridah H; Heitner J; Kerubo MB; Ngure K; Pinder LF; Thomas KK; Mugo NR; Gimbel S Implement Sci; 2023 Jun; 18(1):26. PubMed ID: 37365575 [TBL] [Abstract][Full Text] [Related]
55. Effectiveness of cervical cancer screening using visual inspection with acetic acid in Peru. Luciani S; Munoz S; Gonzales M; Delgado JM; Valcarcel M Int J Gynaecol Obstet; 2011 Oct; 115(1):53-6. PubMed ID: 21820117 [TBL] [Abstract][Full Text] [Related]
56. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study. Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P; PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957 [TBL] [Abstract][Full Text] [Related]
57. Safety, feasibility, and acceptability of visual inspection with acetic acid and immediate treatment with cryotherapy in rural Laos. Phongsavan K; Phengsavanh A; Wahlström R; Marions L Int J Gynaecol Obstet; 2011 Sep; 114(3):268-72. PubMed ID: 21752376 [TBL] [Abstract][Full Text] [Related]
58. Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana. Ramogola-Masire D; Grover S; Mathoma A; Monare B; Gabaitiri L; Bazzett-Matabele L; Hofmeyr G; Morroni C; Luckett R BMC Womens Health; 2022 Apr; 22(1):100. PubMed ID: 35366863 [TBL] [Abstract][Full Text] [Related]
59. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa. Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487 [TBL] [Abstract][Full Text] [Related]
60. Cervical screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy in Fiji. Fong J; Gyaneshwar R; Lin S; Morrell S; Taylor R; Brassil A; Stuart A; McGowan C Asian Pac J Cancer Prev; 2014; 15(24):10757-62. PubMed ID: 25605171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]